Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Kim
Peter J Neumann

Showing results (61-70 of 436) with videos related to

Pageof 44
Sort By:
The New England Journal of Medicine|November 19, 2015
Measuring the Value of Prescription DrugsPeter J Neumann, Joshua T Cohen
Diabetes Care|July 30, 2008
Reducing cardiovascular disease: opportunities and consequencesPeter J Neumann, Joshua T Cohen
Health Affairs (Project Hope)|September 11, 2008
Using decision analysis to better evaluate pediatric clinical guidelinesJoshua T Cohen, Peter J Neumann
Health Services Research|August 19, 2009
A framework to measure the value of public health servicesPeter D Jacobson, Peter J Neumann
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2007
Dialysis facility ownership and epoetin dosing in hemodialysis patients: a medical economic perspectiveJoshua T Cohen, Peter J Neumann
The New England Journal of Medicine|November 2, 2012
Medicare's enduring struggle to define "reasonable and necessary" carePeter J Neumann, James D Chambers
Mabs|March 2, 2012
The cost-effectiveness of biopharmaceuticals: a look at the evidenceAndrew W Wilson, Peter J Neumann
Health Affairs (Project Hope)|June 10, 2015
Medicare's Interventions Coverage: The Authors ReplyJames D Chambers, Peter J Neumann
The New England Journal of Medicine|January 22, 2010
Medicare and medical technology--the growing demand for relevant outcomesPeter J Neumann, Sean R Tunis
The Synthesis Project. Research Synthesis Report|November 5, 2011
Cost savings and cost-effectiveness of clinical preventive carePeter J Neumann, Joshua T Cohen
Pageof 44

Showing results (61-70 of 436) with videos related to

Sort By:
Pageof 44
The New England Journal of Medicine|November 19, 2015
Measuring the Value of Prescription DrugsPeter J Neumann, Joshua T Cohen
Diabetes Care|July 30, 2008
Reducing cardiovascular disease: opportunities and consequencesPeter J Neumann, Joshua T Cohen
Health Affairs (Project Hope)|September 11, 2008
Using decision analysis to better evaluate pediatric clinical guidelinesJoshua T Cohen, Peter J Neumann
Health Services Research|August 19, 2009
A framework to measure the value of public health servicesPeter D Jacobson, Peter J Neumann
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2007
Dialysis facility ownership and epoetin dosing in hemodialysis patients: a medical economic perspectiveJoshua T Cohen, Peter J Neumann
The New England Journal of Medicine|November 2, 2012
Medicare's enduring struggle to define "reasonable and necessary" carePeter J Neumann, James D Chambers
Mabs|March 2, 2012
The cost-effectiveness of biopharmaceuticals: a look at the evidenceAndrew W Wilson, Peter J Neumann
Health Affairs (Project Hope)|June 10, 2015
Medicare's Interventions Coverage: The Authors ReplyJames D Chambers, Peter J Neumann
The New England Journal of Medicine|January 22, 2010
Medicare and medical technology--the growing demand for relevant outcomesPeter J Neumann, Sean R Tunis
The Synthesis Project. Research Synthesis Report|November 5, 2011
Cost savings and cost-effectiveness of clinical preventive carePeter J Neumann, Joshua T Cohen
Pageof 44